Ranbaxy Laboratories (Delisted) share price history

BSE: 500359

Last traded ₹859.80 on 1 Apr 2015

Delisted on 30 Mar 2016.

Last announcements

The company's own last announcements before its shares stopped trading, routine notices left out.Share news and announcements

Mar 2015
- 31 Mar · Disclosure
  Sun Pharmaceutical Industries Ltd has submitted the disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 31 Mar · Disclosure
  Vide letter dated March 30, 2015 a copy of disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 25 Mar · Suspension of trading in equity shares
  Members of the Exchange are hereby informed that the trading in equity shares of Ranbaxy Laboratories Limited shall be suspended w.e.f. April 06, 2015 (i.e. closing hours of trading on April 1, 2015) on account of Scheme of Amalgamation with Sun Pharmaceuticals Industries Limited.
- 25 Mar · Business
  Committee of the Directors of the Company has March 24, 2015, fixed April 07, 2015 as the record date in order to determine .... (opens in a new tab)
- 25 Mar · Corporate action
  Company has fixed Record Date as April 7, 2015 to determine the names of the shareholders of erstwhile Ranbaxy who would be entitled to receive 8 ( eight) equity shares of Re.1 each of the Company for every 10 (ten) equity shares of Rs.5 each of erstwhile Ranbaxy held and to determine the names of the NCD holders who would be entitled to 1 (One) NCD of Rs.1 lac each of the Company for every 1 (One) NCD of Rs.1 lac each held in erstwhile Ranbaxy pursuant to amalgamation of erstwhile Ranbaxy into the Company.
- 24 Mar · Updates
  Intimation about the approval received from Reserve Bank of India and Competition Commission of India in respect of the Scheme of Arrangement between Ranbaxy Laboratories Limited and Sun Pharmaceutical Industries Ltd (opens in a new tab)

Results

Standalone, as consolidated accounts are on record for only 1 of the last ten years; ₹ crore, the charts by years to December, the table by quarter.Quarterly results

Quarter to Dec 2014, against the quarter before

Revenue: ₹1,010 Crdown 23.43%
Net profit: −₹1,420 CrQuarter to Sep 2014: −₹368 Cr
Net margin: −140.7%

Revenue by year

Net profit by year, a loss in red

Net profit
Loss

A loss in 3 of the 6 years shown

The years either side of a change of basis do not compare. From the year to Dec 2008, the company's revenue for that year, ₹4,472 Cr, differs from its quarters added, ₹4,350 Cr.

₹ crore	Mar 2013	Jun 2013	Sep 2013	Dec 2013	Mar 2014	Jun 2014	Sep 2014	Dec 2014
Revenue	1,382	1,439	1,426	1,367	1,252	2,179	1,319	1,010
Net profit	70	−609	−842	−396	898	755	−368	−1,420
Net margin	5.1%	−42.3%	−59.1%	−29.0%	71.7%	34.7%	−27.9%	−140.7%

Standalone. The last eight quarters. The latest is shaded.

Where the return came from

Yearly rates to Dec 2012, per-share figures restated for splits and bonuses.

Over	Return a year	Earnings growth	Change in P/E	Dividend yield
1 year	+24.2%	–	–	0.0%
3 years	−0.9%	–	–	0.0%
5 years	+3.4%	–	–	0.0%

Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.

Ranbaxy Laboratories share price by year

Each calendar year to 2015.

Year	Close at year end	Change	Highest close	Lowest close
2015	859.80	+36.9%	859.80	611.70

₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2015 close is its last trade, on 1 Apr 2015.

Recent sessions

The last 10 trading days to 1 Apr 2015, as traded on BSE.

Date	Open	High	Low	Close	Average price	Volume
1 Apr 2015	814.70	869.70	809.45	859.80	846.55	54,15,702
31 Mar 2015	809.00	824.45	801.95	814.00	814.25	8,87,942
30 Mar 2015	810.10	816.20	790.10	806.65	807.33	5,91,267
27 Mar 2015	827.50	829.50	798.50	805.20	808.51	7,82,388
26 Mar 2015	834.00	834.30	812.20	819.30	823.22	31,57,649
25 Mar 2015	832.00	839.00	820.25	831.20	829.87	24,54,865
24 Mar 2015	811.90	827.60	810.00	819.05	818.57	18,76,044
23 Mar 2015	814.80	821.50	796.60	804.60	808.69	6,78,300
20 Mar 2015	828.00	843.85	803.15	808.90	819.48	12,37,650
19 Mar 2015	825.70	845.35	814.50	824.15	835.44	15,44,895

Prices in ₹ per share as traded, not adjusted.

Price adjustments

What the price chart is corrected for, so it reads as one share held throughout.

Ex-date	Event	Price factor	What happened
16 Sep 2013	Price move	–	Between two trading sessions the price moved by a fifth or more. The company made an announcement in time for trading that day or the trading day before. Not adjusted for.
8 Aug 2013	Price move	–	Between two trading sessions the price moved by a fifth or more. The company's board met on results that day or since the trading day before. Not adjusted for.

Each event is noted and not adjusted for.

Company details

Legal name: Ranbaxy Laboratories Ltd.
BSE code: 500359
ISIN: INE015A01028
Face value: ₹5
Former symbols: RANBAXY
Website: www.ranbaxy.com (opens in a new tab)
CIN: L24231PB1961PLC003747; Corporate identity number, the registrar of companies' code for it